FGAM
Financial Gravity Asset Management Portfolio holdings
AUM
$459M
This Quarter Return
-0.27%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$97.7M
AUM Growth
–
Cap. Flow
+$97.7M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,600
New
1,580
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 9.84% |
| 2 | Technology | 8.15% |
| 3 | Industrials | 4.98% |
| 4 | Financials | 4.69% |
| 5 | Consumer Discretionary | 4.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nomad Foods
NOMD
$2.31B
| $225K | 0.23% |
+13,755
| New | +$225K |
|
77
Qualcomm
QCOM
$170B
| $224K | 0.23% |
+4,462
| New | +$224K |
|
78
DXC Technology
DXC
$2.6B
| $223K | 0.23% |
+2,198
| New | +$223K |
|
79
Microsoft
MSFT
$3.76T
| $221K | 0.23% |
+2,360
| New | +$221K |
|
80
Tyson Foods
TSN
$20B
| $219K | 0.22% |
+3,260
| New | +$219K |
|
81
Lear
LEA
$5.77B
| $213K | 0.22% |
+1,130
| New | +$213K |
|
82
Generac Holdings
GNRC
$10.3B
| $212K | 0.22% |
+4,684
| New | +$212K |
|
|
ALXN
83
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $211K | 0.22% |
+1,845
| New | +$211K |
|
84
Regeneron Pharmaceuticals
REGN
$59.8B
| $211K | 0.22% |
+714
| New | +$211K |
|
85
CAE Inc
CAE
$8.55B
| $210K | 0.21% |
+11,274
| New | +$210K |
|
86
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.7B
| $207K | 0.21% |
+1,358
| New | +$207K |
|
87
General Motors
GM
$55B
| $207K | 0.21% |
+5,721
| New | +$207K |
|
88
Mativ Holdings
MATV
$666M
| $205K | 0.21% |
+5,233
| New | +$205K |
|
89
Labcorp
LH
$22.8B
| $205K | 0.21% |
+1,202
| New | +$205K |
|
90
HP
HPQ
$26.8B
| $204K | 0.21% |
+9,479
| New | +$204K |
|
91
Sonoco
SON
$4.53B
| $203K | 0.21% |
+3,961
| New | +$203K |
|
|
ORAN
92
DELISTED
Orange
ORAN
| $198K | 0.2% |
+10,950
| New | +$198K |
|
93
Nucor
NUE
$33.3B
| $198K | 0.2% |
+3,245
| New | +$198K |
|
|
VIAB
94
DELISTED
Viacom Inc. Class B
VIAB
| $197K | 0.2% |
+6,645
| New | +$197K |
|
95
BioMarin Pharmaceuticals
BMRN
$11.3B
| $195K | 0.2% |
+2,367
| New | +$195K |
|
96
Raymond James Financial
RJF
$33.2B
| $194K | 0.2% |
+2,199
| New | +$194K |
|
97
State Street
STT
$32.1B
| $193K | 0.2% |
+1,978
| New | +$193K |
|
98
Illumina
ILMN
$15.2B
| $193K | 0.2% |
+804
| New | +$193K |
|
99
McCormick & Company Non-Voting
MKC
$18.7B
| $192K | 0.2% |
+1,895
| New | +$192K |
|
100
Jazz Pharmaceuticals
JAZZ
$7.99B
| $192K | 0.2% |
+1,271
| New | +$192K |
|